Thu Oanh Dang, PharmD, BCOP {Chair}
Dang is a hematology/oncology clinical pharmacist at Massachusetts General Hospital (MGH) in Boston, MA since 2018. She is also a residency coordinator for PGY2 oncology at MGH and an adjunct professor at Massachusetts College of Pharmacy Health Sciences (MCPHS). Prior to MGH, Thu worked at Memorial Sloan Kettering CC as a lymphoma/MM specialist for eight years. Thu received her B.S. in biochemistry and PharmD degrees at the University of Washington. She completed PGY1 at the Franciscan Health System and PGY2 oncology pharmacy residency at University of Kansas MC.

Janelle B. Perkins, PharmD, BCOP {Vice Chair}
Perkins is an Associate Professor in the Department of Pharmacotherapeutics and Clinical Research at the University of South Florida College of Pharmacy and practices in the Blood and Marrow Transplant (BMT) Clinic at Moffitt Cancer Center (MCC) in Tampa, Florida. She graduated from University of Florida with a BS Pharm and earned her PharmD from University of North Carolina and completed an oncology pharmacy residency at the VA Hospital in San Antonio, Texas. Prior to her current position, she was a faculty member in the BMT Program at MCC where she served as a principal investigator on clinical trials involving graft-versus-host disease and busulfan pharmacokinetics.

Rabia S. Atayee, PharmD, BCPS, APh 
Atayee is the Associate Dean for Admissions and Outreach and Associate Professor of Clinical Pharmacy at University of California San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS) where she is actively involved in clinical, research, teaching, and external national activities with a focus in palliative care. She developed her role and the presence of a pharmacist on the palliative care team at UCSD Health System under a Collaborative Practice Protocol that has been approved and credentialed to practice under expanded scope of practice. Atayee graduated with a PharmD from University of California, San Francisco School of Pharmacy and went on to complete her residency in acute care at UCSD Medical Center. Atayee is the first pharmacist in Southern California to obtain a DEA license and has the authority to initiate controlled substances for the treatment of her palliative care patients. Her clinical expertise and excellence in patient care is exemplified by the growth of her clinical practice with her major research focus in palliative care with a minor research focus in the area of pharmacy education.

Joseph Bubalo, PharmD, BCPS, BCOP
Bubalo is an oncology pharmacotherapy specialist with Oregon Health & Science University (OHSU) in Portland, Oregon and an Assistant Professor of Medicine with the Division of Hematology and Medical Oncology. He has been active in the clinical care of oncology and stem cell transplant and cellular therapy patients for over 25 years and has received research grants investigating ways to improve multiple areas of supportive care in these patients. He continues to look for ways to decrease the symptoms associated with antineoplastic and associated therapies.

Alexandre Chan, PharmD, MPH, FCCP, FISOPP, BCPS, BCOP, APh
Chan is a Founding Chair and Professor in Clinical Pharmacy at the University of California, Irvine (UCI) School of Pharmacy & Pharmaceutical Sciences. He also serves as an Oncology Pharmacist at the UCI Chao Family Comprehensive Cancer Center and a Visiting Professor at the National Cancer Center Singapore. Chan directs a research program in cancer supportive care and his team has published >240 full-length peer-reviewed manuscripts. He received his PharmD from Rutgers University, completed his PGY1 at University of California San Francisco, PGY2 oncology pharmacy residency at University of California Davis Medical Center and MPH at National University of Singapore. Chan has also held leadership positions in various international medical and pharmacy organizations.

LTC Erik DeFreitas, PharmD, MA, MPH, BCOP
Lieutenant Colonel DeFreitas is the Assistant Deputy Commander of Patient Services at Dwight D. Eisenhower Army Medical Center, Fort Gordon, Georgia. He graduated with a Doctor of Pharmacy from Northeastern University. Completed an Oncology Pharmacy Residency at Walter Reed Army Medical Center and served as Chief of Oncology Pharmacy at Tripler Army Medical Center in Honolulu, HI. In addition, Erik received a MA in National Security from the Naval War College, MPH from Harvard University and completed a fellowship with the RAND Corporation. He has held a variety of leadership positions within the Military Health System in California, Iraq, Hawaii and Washington DC.

Jin Han, PharmD, PhD, BCPS
Jin is an Assistant Professor at College of Pharmacy, University of Illinois at Chicago (UIC) and a Clinical Pharmacist at the UIC Comprehensive Sickle Cell Center. He also co-directs the Personalized Medicine Program at UIC. Jin received his PhD degree from Baylor College of Medicine, and his PharmD degree from UIC. He completed PGY1 residency at Rush University Medical Center in Chicago. His areas of practice and research interest include sickle cell disease, pain management, pharmacogenomics, etc.

Yun Man, PharmD, BCOP
Man is a Medication Use Quality and Policy Specialist at Dana Farber Cancer Institute in Boston, Massachusetts. She received her Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Health Sciences University and completed her PGY1 Pharmacy Practice Residency at VA Illiana Health Care System followed by a PGY2 Oncology Pharmacy Residency at Roswell Park Comprehensive Cancer Center.

Cindy L. O’Bryant, PharmD, BCOP, FCCP, FHOPA  
O’Bryant is a Professor with the Department of Clinical Pharmacy at the University of Colorado Skaggs School Pharmacy and Pharmaceutical Sciences and practices in the Developmental Therapeutics (Phase 1)/ GI/ Head & Neck cancer program where she is a principal investigator of Phase 1 clinical trials and organ dysfunction trials. She serves as director of the PGY2 Oncology Pharmacy Residency Program and Co-Director of the Oncology Clinical Research Fellowship. O’Bryant completed her PharmD at Mercer University and PGY2 Oncology Pharmacy residency at the University of Colorado Health Sciences Center.

Deborah Ward, PharmD, BCOP, BCPS
Dr. Ward graduated with a Bachelor of Science degree in Chemistry from St Joseph’s University and worked for 5 years in the pharmaceutical industry as an Analytical Development Chemist. She then graduated from Temple University with a Bachelor of Science and Doctor of Pharmacy degrees. She completed an ASHP Accredited Residency in Pharmacy Practice at Shands Hospital at the University of Florida as well as a Hematology/Oncology Clinical Fellowship at Virginia Commonwealth University/Medical College of Virginia Hospitals in Richmond, Virginia. Dr Ward is a Clinical Pharmacy Specialist in Pediatric Oncology at St. Jude Children’s Research Hospital in Memphis, Tennessee.